Patients were randomized into two groups and treated with two inhalation twice-daily BUD/FM 160/4 .5 g plus as-needed BUD/FM ( SMART group , n = 15 ) or one inhalation twice-daily FP/SM 250/50g plus as-needed procaterol ( FP/SM group , n = 15 ) for 8 weeks .